Arthritic joint disease
Therapeutic area
Rheumatology
Rare disease
No
- Definition
- An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Arthritic joint disease
- Therapeutic area
- Rheumatology
- arthritic joint disease
- arthritis
- inflammation of skeletal joint
- skeletal joint inflammation
- inflammatory disorder of joint
- Disease mechanisms
- Inflammatory
- All therapeutic areas
- Rheumatology
- Severity
- Moderate
- MONDO ID
- MONDO:0005578
- Parent condition
- MONDO:0002614
Related records
Broader conditions (10)
- Arthropathy
- Bone disorder
- Bone inflammation disease
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Inflammatory disease
- Musculoskeletal system disorder
- Skeletal system disorder
Narrower conditions (55)
- Acute calcific periarthritis
- Adult-onset Still disease
- Ankylosing spondylitis
- Bacterial arthritis
- Chondrocalcinosis
- Chondrocalcinosis 1
- Chondrocalcinosis 2
- Chondrocalcinosis due to apatite crystal deposition
- Chronic childhood arthritis
- Enthesitis-related juvenile idiopathic arthritis
- Escherichia coli discitis
- Felty syndrome
- Fungal discitis
- Gonococcal infection of joint
- Gonococcal synovitis
- Hemophilic arthropathy
- Infectious discitis
- Infective arthritis
- Juvenile ankylosing spondylitis
- Juvenile chronic polyarthritis
Trials (894)
- "Outcomes of Surgical Removal of Foreign Body Granulomas"
- "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology"
- 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
- 2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)
- 3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
- 3D MR Versus 3D CT for Glenohumeral Arthritis
- 3VM for Treatment of Chronic Osteoarthritis Knee Pain
- 99m-Technetium- Glucosamine in Arthritis
- 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity
- A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)
- A 3-Arm Study on G7 Acetabular Cup With Echo BiMetric Stem in Total Hip Arthroplasty
- A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period
- A Bioequivalence Study of Two Different Dosage Form of Genakumab
- A Case Control Study to Define Clinical, Immunologic and Radiographic Features of the Aromatase Inhibitor Arthralgia Syndrome
- A Case Series Comparing T+LRTI to Partial Trapeziectomy for Thumb Osteoarthritis
- A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty
- A Clinical Investigation of the M2a-Magnum™ Hip System
- A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients
- A Comparison of Impingement Free Range of Motion With CT Scan After Manual and Robotic Total Hip Replacement
- A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
Approved drugs (14)
- Acetaminophen
- Adalimumab
- Aspirin
- Camphor
- Capsaicin
- Ibuprofen
- Lidocaine
- Menthol
- Methotrexate
- Methotrexate sodium
- Methyl salicylate
- Naproxen
- Penicillin V
- Prednisone
Drugs in development (12)
- Duvelisib Phase 3
- Eltenac Phase 1
- Esonarimod Phase 3
- MLN-0415 Phase 1
- Oncolysin CD6 Phase 1
- Perakizumab Phase 1
- Pexmetinib Phase 1
- Polmacoxib Phase 3
- RWJ-67657 Phase 1
- Sinomenine Phase 2
- Solcitinib Phase 1
- Zolimomab aritox Phase 2
Other linked drugs (21)
- Benorilate
- Bevifimod
- Dexbrompheniramine maleate
- Esomeprazole magnesium
- Etanercept
- Felbinac
- Fenbufen
- Floctafenine
- Halopredone acetate
- Indomethacin
- Leflunomide
- Meclofenamate sodium
- Meloxicam
- Nafcillin
- Omeprazole
- Oxyphenbutazone
- Phenylephrine hydrochloride
- Rilonacept
- Rimexolone
- Seprilose